Patient capital is an attractive concept in theory. But how does it work in practice? We describe three real situations where a long-term horizon made the difference between success and failure.
We talk a lot about patient capital at Blue Mountain. It is one of the concepts that best defines our investment philosophy. But the expression, repeated frequently, risks becoming an empty slogan if we do not anchor it in reality.
This article describes three real situations — anonymised to protect confidentiality — where a family office’s long-term horizon was the determining factor of the outcome. These are not heroic stories. They are stories of patience, which is something far less glamorous but far more effective.
An industrial family business with 25 million euros in revenue and 3 million EBITDA needed a partner to manage the generational transition. The 68-year-old founder wanted to retire gradually. His 35-year-old son had potential but lacked the necessary experience to assume leadership immediately.
A private equity fund with a four-to-five-year horizon would have needed to accelerate the transition: appoint an external CEO, rapidly professionalise management, and prepare the company for a secondary sale. The founder’s son would have been marginalised.
We acquired a majority stake and designed a five-year transition plan. During the first two years, the founder continued as CEO, with the son as operations director. We hired an external CFO and commercial director. In the third year, the son assumed general management. Five years later, the company revenues reached 38 million with 5.5 million EBITDA. The son leads competently and confidently. The founder is retired but remains connected as an adviser.
A services company with 15 million euros in revenue had entered distress through a combination of factors. EBITDA had fallen to 500,000 euros with difficulty servicing its debt. We acquired the company at a valuation reflecting its financial situation, injected fresh capital, and negotiated a debt restructuring giving the company time to recover.
We did not cut staff indiscriminately. We identified value-generating areas and those that were not. We closed a loss-making business line but reinvested resources into strengthening profitable ones. The stabilisation took eighteen months. Full recovery took three years. The transformation into a solid, growing company took five. Seven years later: 22 million in revenue, 2.8 million EBITDA, more employees than at acquisition.
A logistics company with 8 million revenue and 1 million EBITDA — well-managed with good margins but limited growth capacity. We used it as a platform for long-term sector consolidation. Between each acquisition, we dedicated time to integration before taking the next step. When an acquisition opportunity was not ready for integration, we let it pass. Eight years later: a logistics platform with over 40 million in revenue and 5 million EBITDA, integrating seven companies functioning as a coherent operational unit.
All three cases share a common denominator: time was an essential ingredient of the outcome. Not time as passive waiting, but as a strategic resource that allowed the right decisions at the right moment. Patient capital is not better than impatient capital in the abstract. It is better in a specific context: the Spanish middle-market, where companies are family-owned, where change processes require trust, and where value is created through sustained execution, not financial engineering.
By Dirk Manuel Martens Jiménez
By Dirk Manuel Martens Jiménez
By Dirk Manuel Martens Jiménez
If you wish to explore a potential collaboration or present an investment opportunity, we invite you to contact us. We guarantee absolute confidentiality in all our conversations.